Molecular pathways executing the "trophic sentinel" response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation

Virology

Volumn 319, Issue 1, 2004, Pages 81-93

  Eichten, Alexandra ^a,b   Rud, Debrah S ^a   Grace, Miranda ^a   Piboonniyom, Siribang On ^a,c   Zacny, Valerie ^a   Münger, Karl ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

E7, apoptosis; Fibroblast; HPV 16; Trophic sentinel

Indexed keywords

CASPASE 3; CASPASE 8; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN E7; PROTEIN KINASE B; PROTEIN P53; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DIPLOIDY; DNA BINDING; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 1242315673     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.11.008     Document Type: Article

References (83)

1. Antwerp D., Martin S., Kafri T., Green D., Verma I. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274:1996;787-789.
2. cip1/Waf1 by tumor necrosis factor a induces growth arrest and cytoprotection in normal human keratinocytes. Mol. Cancer Res. 1:2003;262-270.
3. Bates S., Phillips A.C., Clark P.A., Stott F., Peters G., Ludwig R.L., Vousden K.H. p14ARF links the tumour suppressors RB and p53. Nature. 395:1998;124-125.
4. Berezutskaya E., Yu B., Morozov A., Raychaudhuri P., Bagchi S. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Cell Growth Differ. 8:1997;1277-1286.
5. Bissonnette R.P., Echeverri F., Mahboubi A., Green D.R. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359:1992;552-554.
6. Blackstone N.W., Green D.R. The evolution of a mechanism of cell suicide. BioEssays. 21:1999;84-88.
7. Boyer S.N., Wazer D.E., Band V. E7 protein of human papillomavirus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:1996;4620-4624.
8. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 377:1995;646-649.
9. Butt A.J., Dickson K.A., McDougall F., Baxter R.C. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J. Biol. Chem. 278:2003;29676-29685.
10. Cazals V., Nabeyrat E., Corroyer S., de Keyzer Y., Clement A. Role for NF-kappa B in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells. Biochim. Biophys. Acta. 1448:1999;349-362.
11. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
12. Debbas M., White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:1993;546-554.
13. Demers G.W., Halbert C.L., Galloway D.A. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology. 198:1994;169-174.
14. Duensing S., Münger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res. 62:2002;7075-7082.
15. Eichten A., Westfall M., Pietenpol J.A., Münger K. Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein. Virology. 295:2002;74-95.
16. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature. 411:2001;342-348.
17. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
18. Fanidi A., Harrington E.A., Evan G.I. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature. 359:1992;554-556.
19. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23:2002;824-854.
20. Flores E.R., Tsai K.Y., Crowley D., Sengupta S., Yang A., McKeon F., Jacks T. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 416:2002;560-564.
21. Gonzalez S.L., Stremlau M., He X., Basile J.R., Münger K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol. 75:2001;7583-7591.
22. Gottlieb E., Haffner R., von Ruden T., Wagner E.F., Oren M. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 13:1994;1368-1374.
23. Green D., Kroemer G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8:1998;267-271.
24. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
25. Hermeking H., Eick D. Mediation of c-Myc-induced apoptosis by p53. Science. 265:1994;2091-2093.
26. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell Biol. 19:1999;2690-2698.
27. Hsu B., Marin M.C., el-Naggar A.K., Stephens L.C., Brisbay S., McDonnell T.J. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene. 11:1995;175-179.
28. Hueber A.O., Zornig M., Lyon D., Suda T., Nagata S., Evan G.I. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science. 278:1997;1305-1309.
29. Hupp T.R., Meek D.W., Midgley C.A., Lane D.P. Regulation of the specific DNA binding function of p53. Cell. 71:1992;875-886.
30. Jones D.L., Thompson D.A., Münger K. Destabilization of the RB tumor suppressor and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology. 239:1997;97-107.
31. Jones D.L., Thompson D.A., Suh-Burgmann E., Grace M., Munger K. Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway. Virology. 258:1999;406-414.
32. Juin P., Hueber A.O., Littlewood T., Evan G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13:1999;1367-1381.
33. Kiyama S., Morrison K., Zellweger T., Akbari M., Cox M., Yu D., Miyake H., Gleave M.E. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Cancer Res. 63:2003;3575-3584.
34. Lassus P., Opitz-Araya X., Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science. 297:2002;1352-1354.
35. LeRoith D., Roberts C.T. Jr. The insulin-like growth factor system and cancer. Cancer Lett. 195:2003;127-137.
36. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
37. Mannhardt B., Weinzimer S.A., Wagner M., Fiedler M., Cohen P., Jansen-Durr P., Zwerschke W. Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol. Cell Biol. 20:2000;6483-6495.
38. Marchenko N.D., Zaika A., Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 275:2000;16202-16212.
39. Marshman E., Green K.A., Flint D.J., White A., Streuli C.H., Westwood M. Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells. J. Cell Sci. 116:2003;675-682.
40. Mayo M.W., Wang C.Y., Cogswell P.C., Rogers-Graham K.S., Lowe S.W., Der C.J., Baldwin A.S. Jr. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science. 278:1997;1812-1815.
41. McCaig C., Perks C.M., Holly J.M. Signalling pathways involved in the direct effects of IGFBP-5 on breast epithelial cell attachment and survival. J. Cell. Biochem. 84:2002;784-794.
42. McCarthy N.J., Whyte M.K., Gilbert C.S., Evan G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215-227.
43. Miyake H., Nelson C., Rennie P.S., Gleave M.E. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology. 141:2000;2257-2265.
44. Moll U.M., Erster S., Zaika A. p53, p63 and p73 - Solos, alliances and feuds among family members. Biochim. Biophys. Acta. 1552:2001;47-59.
45. Munger K. The role of human papillomaviruses in human cancers. Front. Biosci. 7:2002;d641-d649.
46. Munger K., Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res. 89:2002;213-228.
47. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7:2001;683-694.
48. Nguyen M., Branton P.E., Roy S., Nicholson D.W., Alnemri E.S., Yeh W.C., Mak T.W., Shore G.C. E1A-induced processing of procaspase-8 can occur independently of FADD and is inhibited by Bcl-2. J. Biol. Chem. 273:1998;33099-33102.
49. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058.
50. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46- phosphorylated p53. Cell. 102:2000;849-862.
51. Pan H.C., Griep A.E. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8:1994;1285-1299.
52. Pan H.C., Griep A.E. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9:1995;2157-2169.
53. Pelengaris S., Khan M., Evan G.I. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell. 109:2002;321-334.
54. Phillips A.C., Ernst M.K., Bates S., Rice N.R., Vousden K.H. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell. 4:1999;771-781.
55. Piboonniyom S., Duensing S., Swilling N.W., Hinds P.W., Münger K. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res. 63:2003;476-483.
56. Putzer B.M., Stiewe T., Parssanedjad K., Rega S., Esche H. E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products. Cell Death Differ. 7:2000;177-188.
57. Rao L., Debbas M., Sabbatini P., Hockenbery D., Korsmeyer S., White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7742-7746.
58. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. Role of NF-kB in p53-mediated programed cell death. Nature. 404:2000;892-897.
59. Sakamuro D., Eviner V., Elliott K.J., Showe L., White E., Prendergast G.C. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene. 11:1995;2411-2418.
60. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
61. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505.
62. Seavey S.E., Holubar M., Saucedo L.J., Perry M.E. The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF). J. Virol. 73:1999;7590-7598.
63. Shibue T., Takeda K., Oda E., Tanaka H., Murasawa H., Takaoka A., Morishita Y., Akira S., Taniguchi T., Tanaka N. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 17:2003;2233-2238.
64. Stewart Z.A., Pietenpol J.A. p53 Signaling and cell cycle checkpoints. Chem. Res. Toxicol. 14:2001;243-263.
65. Stoppler H., Stoppler M.C., Johnson E., Simbulan-Rosenthal C.M., Smulson M.E., Iyer S., Rosenthal D.S., Schlegel R. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene. 17:1998;1207-1214.
66. Stott F.J., Bates S., James M.C., McConnell B.B., Starborg M., Brookes S., Palmero I., Ryan K., Hara E., Vousden K.H., Peters G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
67. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
68. Thompson D.A., Belinsky G., Chang T.H.-T., Jones D.L., Schlegel R., Münger K. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene. 15:1997;3025-3036.
69. Thompson D.A., Zacny V., Belinsky G.S., Clason M., Jones D.L., Schlegel R., Münger K. The HPV E7 oncoprotein E7 inhibits tumor necrosis factor α-mediated apoptosis in normal human fibroblasts. Oncogene. 20:2001;3629-3640.
70. Tonner E., Allan G., Shkreta L., Webster J., Whitelaw C.B., Flint D.J. Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. Adv. Exp. Med. Biol. 480:2000;45-53.
71. Tonner E., Barber M.C., Allan G.J., Beattie J., Webster J., Whitelaw C.B., Flint D.J. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development. 129:2002;4547-4557.
72. Vafa O., Wade M., Kern S., Beeche M., Pandita T.K., Hampton G.M., Wahl G.M. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 9:2002;1031-1044.
73. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev., Cancer. 2:2002;594-604.
74. Weinberg R.A. The cat and mouse games that genes, viruses, and cells play. Cell. 88:1997;573-575.
75. White E. Tumour biology. p53, guardian of Rb. Nature. 371:1994;21-22.
76. White E., Grodziker T., Stillman B.W. Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular weight antigen cause the degradation of chromosomal DNA. J. Virol. 52:1984;410-419.
77. White E., Cipriani R., Sabbatini P., Denton A. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65:1991;2968-2978.
78. White E., Sabbatini P., Debbas M., Wold W.S., Kusher D.I., Gooding L.R. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell Biol. 12:1992;2570-2580.
79. White A.E., Livanos E.M., Tlsty T.D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8:1994;666-677.
80. Yeh W.C., Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., Shahinian A., Ng M., Wakeham A., Khoo W., Mitchell K., El-Deiry W.S., Lowe S.W., Goeddel D.V., Mak T.W. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 279:1998;1954-1958.
81. Yu J., Zhang L., Hwang P.M., Kinzler K.W., Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell. 7:2001;673-682.
82. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92:1998;725-734.
83. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev., Cancer. 2:2002;342-350.